MYC and cancer: However, in approximately 70% of cancer cases, MYC is dysregulated, which is characterized by markedly elevated expression levels and excessive activation of its transcriptional function, enabling tumor cells to proliferate uncontrollably and potentially metastasize to nonprimary tissues.